Flurox Ophthalmic Solution

Generic name: fluorescein sodium and benoxinate hydrochloride
Dosage form: ophthalmic solution
Drug class:Ophthalmic diagnostic agents

Medically reviewed by Drugs.com. Last updated on Oct 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. Read further information about unapproved drugs.

FOR USE IN THE EYES ONLY
DESCRIPTION:

Flourescein Sodium and Benoxinate Hydrochloride Opthalmic Solution USP, 0.25%/0.4% is a disclosing agent with rapid anesthetic action of short duration.
Fluorescein Sodium is represented by the following structural formula:

Chemical Name: Spiro [isobenzofuran-1 (3H),9'-[9H] xanthene]-3-one, 3',6' dihydroxy, disodium salt.
Benoxinate Hydrochloride is represented by the following structural formula:


Chemical Name: 2-(Diethylamino) ethyl 4-amino-3butoxybenzoate monohydrochloride.

EACH mL CONTAINS:

ACTIVES: Fluorescein Sodium 2.5mg (0.25%), Benoxinate Hydrochloride 4mg (0.4%)
INACTIVES: Povidone, Boric Acid, Water For Injection. Hydrochloric Acid may be added to adjust pH (4.3 - 5.3).
PRESERVATIVE: Methylparaben 0.1%

CLINICAL PHARMACOLOGY:

This product is the combination of a disclosing agent with a rapidly acting anesthetic of short duration.

INDICATIONS & USAGE:

For procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as
tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures.

CONTRAINDICATIONS:

Known hypersensitivity to any component of this product.

WARNINGS:

Prolonged use of a topical ocular anesthetic is not recommended. It may pro